
The therapeutic approach of motor fluctuations is based on the need for recognizing various types of motor fluctuations for each patient by a meticulous interrogation and also to have a good knowledge of the pharmacology of the various anti-parkinsonian drugs. The treatment of the morning akinesia is linked to the use of anti-parkinsonian drugs with fast action like levodopa in dispersible formulation or apomorphine. The levodopa formulations with prolonged release can be proposed in the treatment of the noctural akinesia. "End of dose" and "on-off" fluctuations require a stable dopaminergic stimulation. It requires the use of drug associations which, for the majority, were never validated by rigorous therapeutic studies. Severe motor fluctuations require the use of apomorphine or chronic stimulation of the subthalamic nucleus.
Movement Disorders, Humans
Movement Disorders, Humans
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
